Showing posts with label Infection. Show all posts
Showing posts with label Infection. Show all posts

Wednesday, June 04, 2014

Research: Ferret H5N1 Infection Via Consumption Of Infected Chicken

image

Photo Credit Wikipedia

 

 

# 8704

 

Although we’ve seen numerous warnings from public health agencies about the dangers of consuming undercooked poultry products in those areas of Asia and the Middle East where H5N1 is endemic, most of the evidence for that risk has been anecdotal.   We’ve seen a relatively small number of human H5N1 infections where consumption of undercooked poultry, or raw duck blood pudding, was been strongly suspected as the route of infection. 

 

Poultry and eggs are considered safe if handled and cooked properly.  Consumption of raw blood pudding (duck or pig), a delicacy in Asia, is probably never a good idea as it carries other additional risks, including Strep Suis infection (see A Streptococcus suis Round Up).

.

 

In 2010, we saw a study (see H5N1 Can Replicate In Human Gut) that provided additional evidence that the bird flu virus can thrive in the human gastrointestinal system. Researchers found that Avian Influenza A(H5N1) Viruses Can Directly Infect and Replicate in Human Gut Tissues.

 

We’ve also seen numerous reports over the years of cats infected with the H5N1 virus after consuming infected birds.  The following comes from a World Health Organization GAR report from 2006.

H5N1 avian influenza in domestic cats

28 February 2006

(EXCERPTS)

Several published studies have demonstrated H5N1 infection in large cats kept in captivity. In December 2003, two tigers and two leopards, fed on fresh chicken carcasses, died unexpectedly at a zoo in Thailand. Subsequent investigation identified H5N1 in tissue samples.

In February 2004, the virus was detected in a clouded leopard that died at a zoo near Bangkok. A white tiger died from infection with the virus at the same zoo in March 2004.

In October 2004, captive tigers fed on fresh chicken carcasses began dying in large numbers at a zoo in Thailand. Altogether 147 tigers out of 441 died of infection or were euthanized. Subsequent investigation determined that at least some tiger-to-tiger transmission of the virus occurred.

 

In 2006, Dr. C.A. Nidom demonstrated that of 500 cats he tested in and around Jakarta, 20% had antibodies for the bird flu virus.  And in 2007 the FAO warned that: Avian influenza in cats should be closely monitored, although so far no sustained virus transmission in cats or from cats to humans has been observed.

 

Dogs are not exempt, as in 2006 the EID Journal published a Dispatch Fatal Avian Influenza A H5N1 in a Dog that documented a a fatal outcome following ingestion of an H5N1-infected duck in Thailand in 2004.

 

In 2011 we looked at a study that examined Gastrointestinal Bird Flu Infection In Cats, and as recently as 2012 the OIE reported on Cats Infected With H5N1 in Israel.

 

All of which brings us to a new short report that appears in Veterinary Research, that attempts to quantify the viral dose needed to infect ferrets through ingestion of infected meat.   First the link and abstract (the entire study is available), and an excerpt from the Discussion, then I’ll be back with a little more.

 

High doses of highly pathogenic avian influenza virus in chicken meat are required to infect ferrets

Kateri Bertran and David E Swayne

Author Affiliations

For all author emails, please log on.

Veterinary Research 2014, 45:60  doi:10.1186/1297-9716-45-60

Published: 3 June 2014

Abstract (provisional)

High pathogenicity avian influenza viruses (HPAIV) have caused fatal infections in mammals through consumption of infected bird carcasses or meat, but scarce information exists on the dose of virus required and the diversity of HPAIV subtypes involved. Ferrets were exposed to different HPAIV (H5 and H7 subtypes) through consumption of infected chicken meat.

The dose of virus needed to infect ferrets through consumption was much higher than via respiratory exposure and varied with the virus strain. In addition, H5N1 HPAIV produced higher titers in the meat of infected chickens and more easily infected ferrets than the H7N3 or H7N7 HPAIV.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

Discussion

In  conclusion,  relatively  high  concentrations  of  H5N1  HPAIV  are  required  to  produce infection  and  death  by  consumption  of  infected  meat  in  ferrets  as  compared  to  respiratory exposure.  Ingestion  of  HPAIV-infected  meat  can  produce  infection  that  primarily  involves  the respiratory tract but can also spread systemically depending on both the virus strain and virus dose received. Although human infections by HPAIV through direct oral contact have  been occasionally reported [12,13], airborne virus or contact with fomites is still considered the main route of exposure in human species [1].

 

Essentially researchers used 9 ferrets per virus tested, dividing them into three groups; low dose, medium dose, and high dose. They then compared morbidity, and mortality, seroconversion rates, and finally necropsy and histopathology test results to determine which viruses were able to infect via the oral consumption route, their effects, and how much of a viral load was required.

 

H5N1 viruses tended to replicate to higher titers in poultry meat than did the H7 viruses tested, and therefore were more infectious. 

 

Interestingly (but not surprisingly), there was a good deal of variability in the ferret outcomes between the two HPAI H5N1 strains (Mong/05 & VN/04) tested. None of the Mong/05 infected ferrets died, and most showed little or no signs of illness. Seven of nine seroconverted. Two of the VN/04 infected ferrets died, while two other seroconverted.

 

As this study illustrates, different clades of the H5N1 virus often demonstrate different degrees of virulence, something we looked at back in 2012 in Differences In Virulence Between Closely Related H5N1 Strains.

 

With the caveat that it is always a bit perilous to transpose animal study results to humans, this study supports the notion that consumption of improperly cooked avian-flu-infected poultry products could be reasonably assumed to pose a health risk.  

 

The good news, at least for ferrets, is that it takes a fairly large helping, and  the `right’ strain of virus, to prove fatal.

Friday, August 23, 2013

MMWR: CDC Imports Investigational Drug For Amoebic Infections

image

L & R: Trophozoites of N. fowleri in brain tissue, stained with H&E. Center: Ameboflagellate trophozoite of N. fowleri. Credit: DPDx

 

#7596

 

Amoebic infections by Naegleria fowleri resulting in PAM (Primary Amebic Meningoencephalitis) or by Acanthamoeba and Balamuthia mandrillaris producing GAE (Granulomatous amoebic encephalitis) are fortunately exceedingly rare, but for the unlucky few who are infected, survival is rare.

 

The CDC only reports one survivor of Naegleria fowleri out of 128 cases diagnosed in the United States (cite) over the past 50 years.

 

Survival from GAE is very rare as well, and those few who do survive usually experience significant neurological impairment.

 

This summer, we’ve already seen a couple of Naegleria infections linked to swimming in freshwater lakes reported in the United States (see Florida Reports Naegleria fowleri Infection, Naegleria fowleri Shuts Water Park), and last year, we saw two cases in Louisiana linked to nasal irrigation using tap water (see FDA Advice On Safe Use Of Neti Pots).

 

Until recently, treatment options have been limited to supportive care, but now the CDC is making available a drug (Miltefosine)– currently used outside of the U.S. to treat visceral and cutaneous leishmaniasis – to victims of FLA (Free Living Amoebic) in the United States.

 

While there’s not a lot of history of using this drug to treat these infections, the CDC believes there is enough evidence that it provides a `survival advantage’ to have imported the drug for this use.


Here is the CDC MMWR release from yesterday:

 

 

Investigational Drug Available Directly from CDC for the Treatment of Infections with Free-Living Amebae

Weekly

August 23, 2013 / 62(33);666-666

Infections caused by free-living amebae (FLA) are severe and life-threatening. These infections include primary amebic meningoencephalitis (PAM) caused by Naegleria fowleri* and granulomatous amebic encephalitis caused by Balamuthia mandrillaris† and Acanthamoeba species.§ Although several drugs have in vitro activity against FLA, mortality from these infections remains >90% despite treatment with combinations of drugs.

 

Miltefosine is a drug used to treat leishmaniasis and also has shown in vitro activity against FLA (1), but as an investigational drug, it has not been readily available in the United States. With CDC assistance, however, miltefosine has been administered since 2009 for FLA infections as single-patient emergency use with permission from the Food and Drug Administration. Although the number of B. mandrillaris and Acanthamoeba species infections treated with a miltefosine-containing regimen is small, it appears that a miltefosine-containing treatment regimen does offer a survival advantage for patients with these often fatal infections (2). Miltefosine has not been used successfully to treat a Naegleria infection, but the length of time it has taken to import miltefosine from abroad has made timely treatment of fulminant Naegleria infections difficult.

 

CDC now has an expanded access investigational new drug (IND) protocol in effect with the Food and Drug Administration to make miltefosine available directly from CDC for treatment of FLA in the United States. The expanded access IND use of miltefosine for treatment of FLA is partly supported by 26 case reports of FLA infection in which miltefosine was part of the treatment regimen (Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, unpublished data, 2013). Miltefosine generally is well-tolerated, with gastrointestinal symptoms the most commonly reported adverse effects. Clinicians who suspect they have a patient with FLA infection who could benefit from treatment with miltefosine should contact CDC to consult with an FLA expert. For diagnostic assistance, specimen collection guidance, specimen shipping instructions, and treatment recommendations, clinicians should contact the CDC Emergency Operations Center at 770-488-7100.

Reported by

Corresponding contributor: Jennifer R. Cope, Div of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, jcope@cdc.gov, 404-718-4878.